These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2452538)

  • 1. [Relation of the immunosuppressivity of virulent Shigella to the structure of O antigen].
    Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):63-7. PubMed ID: 2452538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of immunosuppression factors in Shigella sonnei].
    Frolov AF; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):10-3. PubMed ID: 3532643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Separation of Shigella enterotoxin and immunosuppression factors].
    Borisov VA
    Mikrobiol Zh (1978); 1988; 50(1):77-80. PubMed ID: 3074243
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of shigellae on delayed hypersensitivity in mice infected by different routes].
    Borisov VA; Borisova EV; Solov'eva GA
    Mikrobiol Z; 1994; 56(3):55-9. PubMed ID: 7952228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Shigella toxicity in immunological tolerance].
    Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):95-9. PubMed ID: 2448979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic relationship among virulent enteroinvasive Escherichia coli, Shigella flexneri, and Shigella sonnei detected by ELISA.
    Pál T; Pácsa S; Emödy L; Vörös S
    Lancet; 1983 Jul; 2(8341):102. PubMed ID: 6134933
    [No Abstract]   [Full Text] [Related]  

  • 7. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suppression of the immune response by Shigella in experimental influenza infection in mice].
    Frolov AF; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):104-8. PubMed ID: 6760625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Separation of Shigella toxins into fractions differing in biological activity and characteristics of the fractions inducing penetration in avirulent strains].
    Miroliubova LV; Petrovskaia VG; Lycheva IA; Beliaev DL
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):21-8. PubMed ID: 7034411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis stimulation by an extracellular product of virulent Shigella flexneri 2a.
    Osada Y; Ogawa H
    Microbiol Immunol; 1977; 21(1):49-55. PubMed ID: 323646
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nonspecific Shigella suppression of delayed hypersensitivity].
    Borisov VA; Frolov AF
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):21-4. PubMed ID: 7043973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp.
    Oaks EV; Picking WD; Picking WL
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):242-5. PubMed ID: 8991646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV
    Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipopolysaccharides of Shigella sonnei].
    Borisova EV; Borisov VA
    Prikl Biokhim Mikrobiol; 2000; 36(5):597-602. PubMed ID: 11042887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot.
    Li A; Zhao CR; Ekwall E; Lindberg AA
    Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
    J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunosuppressive activity of Shigella sonnei differing by the presence of plasmid pSS120].
    Borisova EV; Bondarenko VM; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):65-8. PubMed ID: 9460870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cathepsin D activity in splenocytes in relation to Shigella virulence in an experiment].
    Belaia IuA; Khasman EL; Popova LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):72-6. PubMed ID: 6395592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development and use of solid-phase test-systems for the detection of O-antigen of Shigella sonnei and Shigella flexneri].
    Triasuchev IO; Davydov AG; Burkin VS; Pokrovskiĭ VI; Pukhova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):74-7. PubMed ID: 2477970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.